Foresite Capital Management IV as of March 31, 2022
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 9 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 30.5 | $109M | 9.7M | 11.26 | |
| Lyell Immunopharma (LYEL) | 18.8 | $67M | 13M | 5.05 | |
| Pharvaris N V (PHVS) | 16.5 | $59M | 3.3M | 18.14 | |
| Aclaris Therapeutics (ACRS) | 14.0 | $50M | 2.9M | 17.24 | |
| Kura Oncology (KURA) | 8.3 | $30M | 1.8M | 16.08 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 5.8 | $21M | 4.5M | 4.68 | |
| Nurix Therapeutics (NRIX) | 4.0 | $14M | 1.0M | 14.01 | |
| Cymabay Therapeutics | 1.6 | $5.6M | 1.8M | 3.11 | |
| Cue Health (HLTHQ) | 0.5 | $1.7M | 264k | 6.45 |
